secwatch.observer — SEC 8-K summary
======================================

Issuer:     MAXCYTE, INC. (MXCT)
CIK:        0001287098
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001104659-26-002901
Event type: earnings
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MaxCyte reports preliminary FY2025 core revenue in-line with guidance
---------------------------------------------------------------------

- Core revenue Q4 2025 est. $6.6-6.7M; full year $29.5-29.6M.
- SPL program-related revenue Q4 $0.4-0.6M; full year $3.3-3.5M.
- Cash, equivalents & investments ~$155.6M at Dec 31, 2025.
- CEO cites challenging year, cost restructuring, expects revenue growth in H2 2026.
- Preliminary unaudited results; audited FY2025 results due March 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1287098/000110465926002901/0001104659-26-002901-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1287098/000110465926002901/mxct-20260112x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-002901

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer